Dabigatran etexilate mesylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dabigatran etexilate mesylate, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants [Phase 1]